Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Jordan B Singleton; Dennis Wang; Souci Louis; Dallas J Smith; Anastasia S Lambrou; Susan E Beekmann; Claire M Midgley; Philip Polgreen; Shikha Garg; Jessica N Ricaldi; Timothy M Uyeki; Scott Santibañez; Pragna Patel

doi:10.1093/ofid/ofae666

Back

Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Journal article

Open access

Peer reviewed

Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024

Jordan B Singleton, Dennis Wang, Souci Louis, Dallas J Smith, Anastasia S Lambrou, Susan E Beekmann, Claire M Midgley, Philip Polgreen, Shikha Garg, Jessica N Ricaldi, …

Open forum infectious diseases, Vol.11(12), ofae666

12/2024

DOI: 10.1093/ofid/ofae666

PMCID: PMC11604064

PMID: 39610406

Files and links (1)

url

https://doi.org/10.1093/ofid/ofae666View

Published (Version of record) Open Access

Abstract

Abstract Antiviral therapy is underutilized for outpatients at increased risk for severe COVID-19 or influenza. Results from this survey offer insights into treatment barriers from the infectious disease specialist perspective. Further education is needed about the benefits of early antiviral therapy.

antivirals

barriers

COVID-19

influenza

treatment

Details

Title: Subtitle: Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024
Creators: Jordan B Singleton - Centers for Disease Control and Prevention
Dennis Wang - Centers for Disease Control and Prevention
Souci Louis - Centers for Disease Control and Prevention
Dallas J Smith - Centers for Disease Control and Prevention
Anastasia S Lambrou - Centers for Disease Control and Prevention
Susan E Beekmann - University of Iowa
Claire M Midgley - Centers for Disease Control and Prevention
Philip Polgreen - University of Iowa
Shikha Garg - Centers for Disease Control and Prevention
Jessica N Ricaldi - Centers for Disease Control and Prevention
Timothy M Uyeki - Centers for Disease Control and Prevention
Scott Santibañez - Centers for Disease Control and Prevention
Pragna Patel - Centers for Disease Control and Prevention
Resource Type: Journal article
Publication Details: Open forum infectious diseases, Vol.11(12), ofae666
DOI: 10.1093/ofid/ofae666
PMID: 39610406
PMCID: PMC11604064
NLM abbreviation: Open Forum Infect Dis
ISSN: 2328-8957
eISSN: 2328-8957
Publisher: OXFORD UNIV PRESS INC
Grant note: Centers for Disease Control and Prevention: 1 U50 CK00477
This work was supported by Cooperative Agreement Number 1 U50 CK00477, funded by the Centers for Disease Control and Prevention.
Language: English
Electronic publication date: 11/08/2024
Date published: 12/2024
Academic Unit: Infectious Diseases; Epidemiology; Injury Prevention Research Center; Internal Medicine
Record Identifier: 9984748257602771

Metrics

7 Record Views

2 Times Cited - Web of Science